Remove category living-with
article thumbnail

STAT+: Digital tools for diabetes management did not deliver benefits that justify cost, new report finds

STAT

The last decade has seen billions of dollars flow into digital health companies that promise to improve outcomes for the 38 million Americans living with type 2 diabetes. As a result, they don’t reduce health care spending — they drive it up.

Diabetes 339
article thumbnail

Merck announces Remarkable Merck Young Scientists Awards 2023

Express Pharma

Held at Bangalore, the annual awards recognise the work of young scientists who are driving positive change in the lives of millions across India through their cutting-edge research in life sciences.

100
100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Unfortunately, the gross-to-net bubble will remain a fixture for this category, despite a price war led by almost half of the biosimilars.

article thumbnail

Updated Member Categories & Dues Structure Reflect Increased NHC Value

Putting Patients First Blog

Updated Member Categories & Dues Structure Reflect Increased NHC Value January 18, 2024 By: Bob Scott, NHC, Director, Member Services For the past three years, the National Health Council (NHC) has worked with its diverse membership to overcome challenges presented by the COVID-19 pandemic.

52
article thumbnail

USV and Biogenomics launches Insuquick

Express Pharma

Prashant Tewari, Managing Director, USV said,” We are committed to improving the quality of lives of people with diabetes. Dr Sanjay Sonar, Co-Founder and President, Biogenomics said, “Insulin aspart is the first biosimilar in the category of rapid-acting insulin and is a result of more than ten years of R&D efforts.”

article thumbnail

Updated Member Categories, Dues Structure Reflect Increased NHC Value

Putting Patients First Blog

Updated Member Categories, Dues Structure Reflect Increased NHC Value October 26, 2023 By: Randall Rutta, Chief Executive Officer For the past three years, the National Health Council (NHC) has worked with our diverse membership in overcoming the challenges presented by the COVID-19 pandemic.

52
article thumbnail

Comparison Of Rebyota Versus Vowst: A Study Table To Help You Compare Fecal Microbiota Therapies

ID Stewardship

These advancements are evidenced by the two FDA-approved FMT products available for rCDI prevention: Rebyota (Fecal Microbiota, Live-jslm) and Vowst (Fecal Microbiota Spores, Live-brpk). FMT is an evolving area of therapeutics where microbes from healthy donors are introduced into the intestinal tract of recipients.

Hospitals 129